Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dae Hwa Pharm Co Ltd Announces KFDA Approval


Thursday, 28 Feb 2013 12:22am EST 

Dae Hwa Pharm Co Ltd announced that it has received an approval from Korea Food & Drug Administration (KFDA) to initiate a clinical testing for oral paclitaxel and IV paclitaxel. 

Company Quote

7220.0
-50.0 -0.69%
18 Sep 2014